GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veri Medtech Holdings Inc (OTCPK:VRHI) » Definitions » COGS-to-Revenue

VRHI (Veri Medtech Holdings) COGS-to-Revenue : 0.22 (As of Dec. 2021)


View and export this data going back to . Start your Free Trial

What is Veri Medtech Holdings COGS-to-Revenue?

Veri Medtech Holdings's Cost of Goods Sold for the six months ended in Dec. 2021 was $0.01 Mil. Its Revenue for the six months ended in Dec. 2021 was $0.05 Mil.

Veri Medtech Holdings's COGS to Revenue for the six months ended in Dec. 2021 was 0.22.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Veri Medtech Holdings's Gross Margin % for the six months ended in Dec. 2021 was 77.55%.

Veri Medtech Holdings COGS-to-Revenue Historical Data

The historical data trend for Veri Medtech Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veri Medtech Holdings COGS-to-Revenue Chart

Veri Medtech Holdings Annual Data
Trend Dec21
COGS-to-Revenue
0.22

Veri Medtech Holdings Semi-Annual Data
Dec21
COGS-to-Revenue 0.22

Veri Medtech Holdings COGS-to-Revenue Calculation

Veri Medtech Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.011 / 0.049
=0.22

Veri Medtech Holdings's COGS to Revenue for the quarter that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.011 / 0.049
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings  (OTCPK:VRHI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Veri Medtech Holdings's Gross Margin % for the six months ended in Dec. 2021 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.011 / 0.049
=77.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Veri Medtech Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Veri Medtech Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Veri Medtech Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veri Medtech Holdings Inc (OTCPK:VRHI) » Definitions » COGS-to-Revenue
Comparable Companies
MMVVF BLMZ MVNC LDSN VNUE CCCP ABQQ ADD BOTY GFMH NFLX DIS XAMS:UMG LYV WBD FOXA FWONA XPAR:BOL WMG NWSA
Traded in Other Exchanges
N/A
Address
1660 International Dr, Suite 600, McClean, VA, USA, 22101
Website
https://www.verimedtech.com
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.

Veri Medtech Holdings Headlines

From GuruFocus

Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone | VRHI Stock News

By GuruFocus News • 05-15-2025

Veri Medtech (VRHI) Retains PCAOB Auditor | VRHI Stock News

By GuruFocus News • 04-28-2025

Light Media Network Stands In Solidarity With Black Information Network

By Marketwired Marketwired • 07-14-2020

Veri Medtech (VRHI) Relaunches DosePop.com | VRHI Stock News

By GuruFocus News • 05-05-2025